Sunshine Biopharma, Inc - FORM 10-Q - EX-32 - CERTIFICATION OF CHIEF EXECUTIVE AND CHIEF FINANCIAL OFFICERS - August 3, 2010

Attached files

file filename
10-Q - FORM 10Q FOR QUARTER ENDED JUNE 30, 2010 - Sunshine Biopharma, Incfm10q_3-10.htm
EX-3.5 - ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION - Sunshine Biopharma, Incexh3-5.htm
EX-3.4 - STATEMENT OF SHARE AND EQUITY CAPITAL EXCHANGE - Sunshine Biopharma, Incexh3-4.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - Sunshine Biopharma, Incexh31-1.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - Sunshine Biopharma, Incexh31-2.htm

 
 

Exhibit 32

CERTIFICATION PURSUANT TO
18 USC, SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this quarterly report of Sunshine Biopharma, Inc. (the “Company”) on Form 10-Q for the six month period ended June 30, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, the undersigned, in the capacities and on the date indicated below, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of our knowledge:

 
1.
The Report fully complies with the requirements of Rule 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Dated:  August 3, 2010
s/Steve N. Slilaty_____________________
Steve N. Slilaty, Chief Executive Officer
   
   
Dated:  August 3, 2010
s/Camille Sebaaly_____________________
Camille Sebaaly, Chief Financial Officer
   


 
 
 

Sunshine Biopharma, Inc Reports